Lupin has informed about a Press Release as regards receipt of USFDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules, to market a generic version of AstraZeneca Pharmaceuticals LP's (AstraZeneca) Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.
The above information is a part of company’s filings submitted to BSE.